Does hormone therapy affect blood pressure changes in the Diabetes Prevention Program?

OBJECTIVES: To examine whether blood pressure reductions differ by estrogen use among overweight glucose-intolerant women. METHODS: We conducted a secondary analysis of postmenopausal Diabetes Prevention Program participants who used oral estrogen with or without progestogen at baseline and at 1-yea...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Kim, Catherine, Golden, Sherita H., Kong, Shengchun, Nan, Bin, Mather, Kieren J., Barrett-Connor, Elizabeth
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3858523/
https://ncbi.nlm.nih.gov/pubmed/23942251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0b013e3182a0e3ea
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg